1. Home
  2. NBY vs ABVC Comparison

NBY vs ABVC Comparison

Compare NBY & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

N/A

Current Price

$1.54

Market Cap

31.6M

Sector

N/A

ML Signal

N/A

Logo ABVC BioPharma Inc.

ABVC

ABVC BioPharma Inc.

N/A

Current Price

$1.20

Market Cap

30.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NBY
ABVC
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.6M
30.9M
IPO Year
2007
2009

Fundamental Metrics

Financial Performance
Metric
NBY
ABVC
Price
$1.54
$1.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
605.1K
51.9K
Earning Date
03-31-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
35.42
7.14
EPS
0.76
N/A
Revenue
$370,000.00
$509,589.00
Revenue This Year
$23.91
N/A
Revenue Next Year
$32.05
N/A
P/E Ratio
$1.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$0.69
52 Week High
$19.95
$4.02

Technical Indicators

Market Signals
Indicator
NBY
ABVC
Relative Strength Index (RSI) 48.61 34.18
Support Level $0.99 $1.18
Resistance Level $1.85 $1.67
Average True Range (ATR) 0.22 0.12
MACD 0.11 0.00
Stochastic Oscillator 55.41 2.94

Price Performance

Historical Comparison
NBY
ABVC

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Share on Social Networks: